Veterinary Medicines

Nafpenzal DC Suspensie voor intramammair gebruik

Authorised
  • Benzylpenicillin procaine
  • Dihydrostreptomycin sulfate
  • Nafcillin sodium
Download as PDF

Product identification

Medicine name:
Nafpenzal DC Suspensie voor intramammair gebruik
Nafpenzal DC Suspension intramammaire
Nafpenzal DC Suspension zur intramammären Anwendung
Active substance:
  • Benzylpenicillin procaine
  • Dihydrostreptomycin sulfate
  • Nafcillin sodium
Target species:
  • Cattle
Route of administration:
  • Intramammary use

Product details

Active substance and strength:
  • Benzylpenicillin procaine
    300.00
    milligram(s)
    /
    3.00
    gram(s)
  • Dihydrostreptomycin sulfate
    125.00
    milligram(s)
    /
    3.00
    gram(s)
  • Nafcillin sodium
    109.00
    milligram(s)
    /
    3.00
    gram(s)
Pharmaceutical form:
  • Intramammary suspension
Withdrawal period by route of administration:
  • Intramammary use
    • Cattle
      • Meat and offal
        5
        week
      • Milk
        no withdrawal period
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ51RC23
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Belgium
Package description:
  • Nafpenzal DC 100 Intramammary syringes with 3 g of Intramammary suspension
  • Nafpenzal DC 6 x 20 Intramammary syringes with 3g of Intramammary suspension
  • Nafpenzal DC 20 Intramammary syringes with 3g of Intramammary suspension
  • Nafpenzal DC 5 x 4 Intramammary syringes with 3g of Intramammary suspension

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Intervet International B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
  • INTERVET INTERNATIONAL B.V.
Responsible authority:
  • Federal Agency For Medicines And Health Products
Authorisation number:
  • BE-V023572
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 21/12/2023
Download
French (PDF)
Published on: 8/12/2023
Download

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 8/12/2023
Download
French (PDF)
Published on: 8/12/2023
Download
German (PDF)
Published on: 8/12/2023
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."